Momentum was founded to develop rapid tests for critically-important clinical specimens within the hospital microbiology laboratory. The company is headquartered near Cardiff and has a R&D facility near Oxford in the UK.
Momentum has created a new innovative technology for in-vitro diagnostic testing supporting the global fight against antibiotic resistance and the need for improved antibiotic stewardship. The technology rapidly and universally detects viable micro-organisms using a unique combination of a phenotypic marker and ultra-sensitive molecular PCR measurement. Momentum is developing a number of products and applications for the use of its ETGA® technology. The first of these products, Cognitor® Minus, universally targets the rapid exclusion of bacteria and fungi in blood in one day vs five days in blood culture. Cognitor® Minus is CE marked and was launched at ECCMID 2015.